These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29108386)

  • 61. Functional annotation of colorectal cancer susceptibility loci identifies MLH1 rs1800734 associated with MSI patients.
    Ma G; Ge Y; Gu D; Du M; Chu H; Chen J; Zhang Z; Wang M
    Gut; 2016 Jul; 65(7):1227-8. PubMed ID: 26911399
    [No Abstract]   [Full Text] [Related]  

  • 62. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance.
    Scarpa M; Ruffolo C; Canal F; Scarpa M; Basato S; Erroi F; Fiorot A; Dall'Agnese L; Pozza A; Porzionato A; Castagliuolo I; Dei Tos AP; Bassi N; Castoro C
    Oncotarget; 2015 Dec; 6(41):43472-82. PubMed ID: 26496037
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The hMLH1 -93G>A Polymorphism and Risk of Ovarian Cancer in the Chinese Population.
    Niu L; Li S; Liang H; Li H
    PLoS One; 2015; 10(8):e0135822. PubMed ID: 26275295
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Glutathione S-transferase P1 gene rs4147581 polymorphism predicts overall survival of patients with hepatocellular carcinoma: evidence from an enlarged study.
    Wang Z; Qu K; Niu W; Lin T; Xu X; Huang Z; Liu S; Liu S; Chang H; Liu Y; Dong X; Liu C; Zhang Y
    Tumour Biol; 2016 Jan; 37(1):943-52. PubMed ID: 26260272
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma.
    Riazy M; Kalloger SE; Sheffield BS; Peixoto RD; Li-Chang HH; Scudamore CH; Renouf DJ; Schaeffer DF
    Mod Pathol; 2015 Oct; 28(10):1383-9. PubMed ID: 26226846
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer.
    Ma J; Zhang Y; Shen H; Kapesa L; Liu W; Zeng M; Zeng S
    Tumour Biol; 2015 Dec; 36(12):9599-609. PubMed ID: 26142736
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
    Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A;
    Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Application of single-cell genomics in cancer: promise and challenges.
    Wills QF; Mead AJ
    Hum Mol Genet; 2015 Oct; 24(R1):R74-84. PubMed ID: 26113645
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort study.
    Harkness EF; Barrow E; Newton K; Green K; Clancy T; Lalloo F; Hill J; Evans DG
    J Med Genet; 2015 Aug; 52(8):553-6. PubMed ID: 26101330
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SNP genotyping and population genomics from expressed sequences - current advances and future possibilities.
    De Wit P; Pespeni MH; Palumbi SR
    Mol Ecol; 2015 May; 24(10):2310-23. PubMed ID: 25808983
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family.
    Cini G; Carnevali I; Quaia M; Chiaravalli AM; Sala P; Giacomini E; Maestro R; Tibiletti MG; Viel A
    Carcinogenesis; 2015 Apr; 36(4):452-8. PubMed ID: 25742745
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Polymorphisms in microRNA target sites of forkhead box O genes are associated with hepatocellular carcinoma.
    Tan C; Liu S; Tan S; Zeng X; Yu H; Li A; Bei C; Qiu X
    PLoS One; 2015; 10(3):e0119210. PubMed ID: 25739100
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Global cancer statistics, 2012.
    Torre LA; Bray F; Siegel RL; Ferlay J; Lortet-Tieulent J; Jemal A
    CA Cancer J Clin; 2015 Mar; 65(2):87-108. PubMed ID: 25651787
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma.
    Nogueira GA; Lourenço GJ; Oliveira CB; Marson FA; Lopes-Aguiar L; Costa EF; Lima TR; Liutti VT; Leal F; Santos VC; Rinck-Junior JA; Lima CS
    Int J Cancer; 2015 Aug; 137(4):810-8. PubMed ID: 25598504
    [TBL] [Abstract][Full Text] [Related]  

  • 76. DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells.
    Fukuhara S; Chang I; Mitsui Y; Chiyomaru T; Yamamura S; Majid S; Saini S; Hirata H; Deng G; Gill A; Wong DK; Shiina H; Nonomura N; Dahiya R; Tanaka Y
    Oncotarget; 2014 Nov; 5(22):11297-307. PubMed ID: 25526032
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multiplex SNP detection in multiple codons for accurate drug therapy.
    Sayyed DR; Nimse SB; Song KS; Sung N; Kim T
    Chem Commun (Camb); 2014 Dec; 50(93):14585-8. PubMed ID: 25307892
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
    Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
    J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The hMLH1 -93G>A promoter polymorphism is associates with outcomes in oral squamous cell carcinoma patients.
    Lin LH; Lin MW; Mar K; Lin CS; Ji DD; Lee WP; Lee HS; Cheng MF; Hsia KT
    Ann Surg Oncol; 2014 Dec; 21(13):4270-7. PubMed ID: 25047469
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Advanced mass spectrometry-based multi-omics technologies for exploring the pathogenesis of hepatocellular carcinoma.
    Nie W; Yan L; Lee YH; Guha C; Kurland IJ; Lu H
    Mass Spectrom Rev; 2016; 35(3):331-49. PubMed ID: 24890331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.